MEDICAL TRANSCRIPTION BLG CO - COM (MTBC)

CUSIP: 58464J105

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM
Total 13F shares
270,359
Share change
+45,954
Total reported value
$705,000
Price per share
$2.61
Number of holders
11
Value change
+$159,449
Number of buys
5
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 58464J105?
CUSIP 58464J105 identifies MTBC - MEDICAL TRANSCRIPTION BLG CO - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MEDICAL TRANSCRIPTION BLG CO - COM (MTBC) as of Q4 2017

As of 31 Dec 2017, MEDICAL TRANSCRIPTION BLG CO - COM (MTBC) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 270,359 shares. The largest 10 holders included Vanguard Group Inc, PRICE T ROWE ASSOCIATES INC /MD/, GEODE CAPITAL MANAGEMENT, LLC, PANAGORA ASSET MANAGEMENT INC, QCI ASSET MANAGEMENT INC/NY, BURNS J W & CO INC/NY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Virtu Financial LLC, UBS Group AG, and DEUTSCHE BANK AG\. This page lists 11 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.